Expand ORGO Menu
ORGO MENU

ORGO Latest Press Releases

-- August 6, 2026 --

Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- July 27, 2026 --

Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity in the Most Challenging and Complex Venous Leg Ulcers Globe Newswire 4:05 PM

-- July 9, 2026 --

One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics PRNewswire 8:17 AM
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 Globe Newswire 7:30 AM

-- July 6, 2026 --

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu for the Management of Symptomatic Knee Osteoarthritis Globe Newswire 4:05 PM

-- June 18, 2026 --

Regenerative Medicine's Next Chapter: Inside the Race to Make the Body Rebuild Itself Globe Newswire 12:42 PM

-- June 16, 2026 --

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It Globe Newswire 10:30 AM

-- May 7, 2026 --

Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- April 28, 2026 --

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu Globe Newswire 4:30 PM

-- April 15, 2026 --

Organogenesis Holdings, Inc. Investigated by the Portnoy Law Firm Globe Newswire 9:00 AM

-- April 6, 2026 --

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPlyAM Globe Newswire 7:02 PM
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu for Knee Osteoarthritis Pain Globe Newswire 5:30 PM
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026 Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes